An Arnold-Chiari malformation is a congenital central nervous system defect. Raised intracranial pressure is commonly observed, and posterior decompression neurosurgery is the treatment of choice. We describe a patient with iatrogenic occlusion of bilateral jugular veins, subclavian vein, and superior vena cava resulting from repeated central venous cannulations. Because of venous hypertension, the patient suffered from neurologic symptoms: headaches, vision disturbances, and marked head edema. Two stents were used to recanalize the right internal jugular vein and superior vena cava. Symptoms subsided, and the patient returned to work. During 24-month follow-up, stents were patent. The patient remains symptom free and continues working. (J Vasc Surg Cases and Innovative Techniques 2020;6:18-20.) Keywords: Vena cava obstruction; Endovascular treatment; Stenting An Arnold-Chiari malformation is a congenital defect in which the cerebellum structures are displaced into the upper spinal canal. A diagnosis is based on the patient's history, careful observation, and neuroimaging (computed tomography [CT] or magnetic resonance imaging), which provides detailed insight into brain structures and especially the cerebellum. Typically, symptoms exhibited by patients suffering from ArnoldChiari malformation are a consequence of structural congenital defects in the brain and spinal cord. Neurosurgery, the only treatment, is aimed at elimination of the cause; it consists of a posterior fossa decompression, most frequently Pudenz ventriculoperitoneal or ventriculoatrial shunt placement, resulting in a decrease of intracranial pressure and symptom alleviation.
An Arnold-Chiari malformation is a congenital defect in which the cerebellum structures are displaced into the upper spinal canal. A diagnosis is based on the patient's history, careful observation, and neuroimaging (computed tomography [CT] or magnetic resonance imaging), which provides detailed insight into brain structures and especially the cerebellum. Typically, symptoms exhibited by patients suffering from ArnoldChiari malformation are a consequence of structural congenital defects in the brain and spinal cord. Neurosurgery, the only treatment, is aimed at elimination of the cause; it consists of a posterior fossa decompression, most frequently Pudenz ventriculoperitoneal or ventriculoatrial shunt placement, resulting in a decrease of intracranial pressure and symptom alleviation.
Because of repeated central venous cannulation, patients with Arnold-Chiari malformations are at risk for complications that may lead to occlusion of the jugular veins, subclavian veins, or superior vena cava (SVC). This iatrogenic disease of the venous system caused our patient to develop symptoms suggestive of intracranial hypertension. We obtained the patient's consent for the publication of clinical data. confirmed that both stents were in the correct position; adequate venous outflow from the head was also seen (Fig 2) . The postinterventional course was uncomplicated; the patient's condition improved, head edema decreased, and he was discharged on postoperative day 3.
CASE REPORT
During the 30-day observation period, the patient was pre- 
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Volume 6, Number 1 the treatment, he underwent CT angiography, which revealed patency of both stents and satisfactory venous outflow from the head; no stent displacement was found. Color duplex Doppler ultrasound and CT angiography (Fig 3) performed at 24 months after the procedure confirmed stent patency and increased venous flow velocity; no stent thrombosis was visualized. During 24-month follow-up, the patient continued working, did not report any neurologic symptoms, and continued pharmacotherapy as specified before. No complications of anticoagulation treatment were observed.
DISCUSSION
Our patient with an Arnold-Chiari malformation is not among those typically treated with endovascular interventions. The need for endovascular treatment was associated with symptoms of iatrogenic occlusion of the jugular and subclavian veins as well as SVC occlusion revealed on history taking and resulting from multiple intravenous cannulations. The symptoms placed an enormous burden on the patient's everyday life, excluding him from work and causing severe depression. An attempt at endovascular treatment of intracranial hypertension resulting from stenosis or occlusion of the venous system was based on widely available publications regarding the efficacy of such treatment strategies. [1] [2] [3] [4] Because no clear recommendations are available regarding covered and uncovered stent placement, we decided to insert an uncovered Zilver Vena, a dedicated venous stent, at the SVC recanalization site. Although Haddad et al 5 suggested higher effectiveness of covered stents, they also emphasized the need for further studies in this area. Polytetrafluoroethylene-covered self-expanding or balloon-expandable stents definitely prevent passage of thrombi through the mesh. However, uncovered stents are less rigid and less thrombogenic; they allow better adaptation to vessel anatomy. The increasing use of dedicated venous stents might improve treatment outcomes. The risk of the procedure was considered low as major post-stenting complications (SVC rupture, mediastinal hemorrhage, cardiac tamponade, or pulmonary embolism) are rare. Other complications include chest pain, hemoptysis, and approach-related complications. SVC stent migration into the right atrium is another serious issue; its prevalence may be limited by proper device size and positioning. The most frequent long-term complications are stent thrombosis and in-stent restenosis resulting from thrombus formation or external compression. Fortunately, repeated endovascular treatment is possible. 6, 7 There is no consensus with respect to effective anticoagulant therapy for prevention of stent thrombosis after SVC recanalization. Oral anticoagulants or antiplatelet agents are typically used for several months. No comparative studies are yet available to analyze both strategies in this group of patients. [6] [7] [8] [9] The antithrombotic regimen used in our patient during a 30-day follow-up (ie, low-molecular-weight heparin and dual antiplatelet therapy) resulted from our experience in endovascular treatment of arterial disease and thrombosis prevention. Aggressive management was associated with the extent of recanalization and stent length exceeding 120 mm. Long-term antithrombotic therapy (dabigatran 110 mg and aspirin 75 mg daily) seems to have been an effective strategy in our patient.
CONCLUSIONS
Considering literature reports indicating relatively low complication rates after endovascular treatment of iatrogenic and post-thrombotic venous occlusion, we decided to use an endovascular intervention. Early and long-term effects were consistent with literature data; hence, it was concluded that endovascular procedures could be considered the treatment of choice in patients with structural defects and associated conditions.
